Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $26.5400 (-1.37%) ($26.4400 - $27.2500) on Wed. Feb. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.89% (three month average) | RSI | 44 | Latest Price | $26.5400(-1.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.3% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(59%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -1.445% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-6%) IGOV(-4%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.445% (StdDev 2.89%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
1 - 5 Day Possible Target | $20.48(-22.83%) | Resistance Level | $27.56 | 5 Day Moving Average | $26.79(-0.93%) | 10 Day Moving Average | $27.16(-2.28%) | 20 Day Moving Average | $27.56(-3.7%) | To recent high | -19% | To recent low | 9.7% | Market Cap | $1.648b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |